An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Organ donation registration can be completed through the Ohio Bureau of Motor Vehicles. Living donors can contact one of two ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

People with type 1 diabetes are more likely to develop kidney disease if they are repeatedly losing and gaining weight, new ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...